Treatment as Prevention®

Julio González Montaner: orgullo argentino que busca sin descanso una cura definitiva al HIV

Hace casi cuatro décadas que el médico argentino trabaja en una solución para erradicar una de las peores epidemias de la historia de la humanidad. Su camino en busca de una cura deja día a día una huella profunda en la comunidad política y científica de todo el mundo. A principios de la década del […]

Julio González Montaner: orgullo argentino que busca sin descanso una cura definitiva al HIV Read More »

Opinion: BC needs to step up and provide access to long-acting HIV medications

I have been living with HIV (Human Immunodeficiency Virus) for 38 years, and have had an undetectable viral load (less than 40 copies/mL) since 1998. Both of these facts are possible because of activism, community care, and HIV medications. BC has been my home for 28 years. I chose to live here because this province,

Opinion: BC needs to step up and provide access to long-acting HIV medications Read More »

Stigma and discrimination against people with HIV are as big an issue as ever

Preliminary results from a survey of stigma and discrimination conducted by the European Centre for Disease Prevention and Control (ECDC) show that people living with HIV in Europe are as likely to have experienced stigma in recent years as they were a decade ago. This is particularly the case with some types of stigma experienced in healthcare settings,

Stigma and discrimination against people with HIV are as big an issue as ever Read More »

Three faculty members elected as Fellows of the Canadian Academy of Health Sciences

UBC faculty of medicine’s Drs. Karim Khan, Kathleen Martin Ginis and Julio Montaner are among 71 new Fellows elected into the Canadian Academy of Health Sciences (CAHS) for 2022. Election to Fellowship in the CAHS is considered one of the highest honours for individuals in the Canadian health sciences community. “I would like to personally

Three faculty members elected as Fellows of the Canadian Academy of Health Sciences Read More »

Seventy-one new Fellows elected into the Canadian Academy of Health Sciences

Fellows’ accomplishments recognized by peers for contributions to the promotion of health science Ottawa, ON – August 31 2022 – The Canadian Academy of Health Sciences (CAHS) is pleased topresent the list of individuals that were elected as Fellows for 2022. CAHS is proud to recognizeexcellence in health sciences and these new Fellows reflect a

Seventy-one new Fellows elected into the Canadian Academy of Health Sciences Read More »

“Increased Screening, More Outreach, More Support”: Ending Viral Hepatitis

Today, July 28, is World Hepatitis Day. Viral hepatitis is an inflammation of the liver, and its various types account for a significant disease burden worldwide. To delve into the current disease state of hepatitis, and the steps that need taken to end hepatitis transmission by 2030, Contagion interviewed internal medicine specialist Thomas Robertson, MD,

“Increased Screening, More Outreach, More Support”: Ending Viral Hepatitis Read More »

Reflections of award-winning HIV activist, Bob Leahy. U=U guru. Change-maker. All round rabble-rouser.

HIV activism dramatically changes lives. But it takes an impassioned type to transform them. To push back and make noise. To tirelessly pursue this sort of change takes courage, tenacity and a deep understanding of issues. James Watson sits down with celebrated HIV activist Bob Leahy, who at 75 is the very embodiment of the

Reflections of award-winning HIV activist, Bob Leahy. U=U guru. Change-maker. All round rabble-rouser. Read More »

Partnership leads to better care for those with schizophrenia

Today is World Schizophrenia Day, a day to raise awareness about this illness and to eradicate the myths and stigma attached to mental illnesses in general. Schizophrenia affects more than 24 million people worldwide, according to the World Health Organization. Common symptoms include thinking disorder, delusions, hallucinations, and negative syndrome. These induce severe loss of

Partnership leads to better care for those with schizophrenia Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below